NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases

Published:2008-07-18 Issue:5 Volume:62 Page:1053-1056
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Livermore D. M.,Mushtaq S.,Warner M.,Miossec C.,Woodford N.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/62/5/1053/2160829/dkn320.pdf

Reference8 articles.

1. CTX-M: changing the face of ESBLs in the UK

2. CTX-M: changing the face of ESBLs in Europe

3. First Report of the Emergence of CTX-M-Type Extended-Spectrum β-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System

4. Emergence of PER and VEB extended-spectrum -lactamases in Acinetobacter baumannii in Belgium

5. Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics unveil key pathways underlying the synergistic activities of aztreonam and avibactam against multidrug-resistant Escherichia coli;European Journal of Clinical Microbiology & Infectious Diseases;2024-05-09

2. Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa;Clinical Infectious Diseases;2024-02-02

3. Drug Discovery in the Field of β-Lactams: An Academic Perspective;Antibiotics;2024-01-08

4. OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline;Antimicrobial Agents and Chemotherapy;2022-08-16

5. The primary pharmacology of ceftazidime/avibactam: in vitro translational biology;Journal of Antimicrobial Chemotherapy;2022-06-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3